Journal
EXPERT OPINION ON DRUG DELIVERY
Volume 6, Issue 12, Pages 1261-1282Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/17425240903307423
Keywords
cochleate; complexing agent; cyclodextrin; dendrimer; i.v. formulation; liposome; liquid crystalline nanoparticle; nanoparticle; polymeric micellar system; prodrug
Categories
Funding
- Abbott Laboratories
Ask authors/readers for more resources
In recent years, with the widespread application of high-throughput screening technologies in drug discovery, an increasing number of new chemical entities with extremely poor aqueous solubility have been generated. Their poor solubility represents a major challenge for formulation of these compounds for both oral and parenteral administration. Formulations for intravenous (i.v.) application are of significant importance because they are frequently used in several key therapeutic areas, such as oncology and anesthesia. Furthermore, i.v. formulations of new compounds are often needed to determine basic biopharmaceutical parameters and to obtain proof of concept results in the early phase of product development. This review provides an overview of the recent advances in formulation approaches and drug delivery technologies for poorly water-soluble compounds applicable to i.v. administration. The advantages and disadvantages of different strategies are highlighted and an expert opinion on each technical field is presented.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available